Euglycemic Diabetic Ketoacidosis - Can You Identify & Treat This Novel Syndrome - Self-Study

Course overview

In recent months, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have become available for the treatment of insulin-dependent diabetes mellitus in feline patients. One of the rare potential side effects of this class of medication is euglycemic diabetic ketoacidosis (eDKA). Learners will review the relevant pathophysiology of, as well as diagnostic testing and therapeutic interventions for cats suspected or confirmed to be living with eDKA.